Literature DB >> 27448549

Thiamine and dystonia 16.

Antonio Costantini1, Erika Trevi2, Maria Immacolata Pala1, Roberto Fancellu3.   

Abstract

Primary torsion dystonia is a movement disorder characterised by sustained or intermittent involuntary muscle contractions causing abnormal movements, postures or both. In this study, 3 brothers affected by inherited primary dystonia 16 (DYT16) began an oral therapy with high-dose thiamine from November to December 2015. After 3 months, an important improvement of the motor symptoms was observed. Our results support the hypothesis that pathogenesis of the symptoms might be related to a dysfunction in mitochondrial oxidative phosphorylation due to a focal impairment of thiamine-dependent processes. Our results support some authors' hypothesis that dystonia might have a mitochondrial aetiology. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27448549      PMCID: PMC4964157          DOI: 10.1136/bcr-2016-216721

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Mitochondria and dystonia: the movement disorder connection?

Authors:  D C Wallace; D G Murdock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.

Authors:  Mercedes Serrano; Mónica Rebollo; Christel Depienne; Agnès Rastetter; Emilio Fernández-Álvarez; Jordi Muchart; Loreto Martorell; Rafael Artuch; José A Obeso; Belén Pérez-Dueñas
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 4.  Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis.

Authors:  Julie Phukan; Alberto Albanese; Thomas Gasser; Thomas Warner
Journal:  Lancet Neurol       Date:  2011-10-24       Impact factor: 44.182

Review 5.  Defects of thiamine transport and metabolism.

Authors:  Garry Brown
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

6.  Thiamine-Responsive and Non-responsive Patients with PDHC-E1 Deficiency: A Retrospective Assessment.

Authors:  Sanne van Dongen; Ruth M Brown; Garry K Brown; David R Thorburn; Avihu Boneh
Journal:  JIMD Rep       Date:  2014-04-10

7.  Thiamine and magnesium deficiencies: keys to disease.

Authors:  D Lonsdale
Journal:  Med Hypotheses       Date:  2014-12-15       Impact factor: 1.538

8.  PRKRA Mutation Causing Early-Onset Generalized Dystonia-Parkinsonism (DYT16) in an Italian Family.

Authors:  Marialuisa Quadri; Simone Olgiati; Mariachiara Sensi; Francesca Gualandi; Elisabetta Groppo; Vittorio Rispoli; Josja Graafland; Guido J Breedveld; Giovanni Fabbrini; Alfredo Berardelli; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2016-03-17       Impact factor: 10.338

9.  Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study.

Authors:  Antonio Costantini; Maria Immacolata Pala; Enzo Grossi; Stella Mondonico; Luisa Ercoli Cardelli; Carina Jenner; Sabrina Proietti; Marco Colangeli; Roberto Fancellu
Journal:  J Altern Complement Med       Date:  2015-10-27       Impact factor: 2.579

10.  Thiamine transporter-2 deficiency: outcome and treatment monitoring.

Authors:  Juan Darío Ortigoza-Escobar; Mercedes Serrano; Marta Molero; Alfonso Oyarzabal; Mónica Rebollo; Jordi Muchart; Rafael Artuch; Pilar Rodríguez-Pombo; Belén Pérez-Dueñas
Journal:  Orphanet J Rare Dis       Date:  2014-06-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.